文献速递血液净化与透析

健康保险与美国腹膜透析使用的关系

Health Insurance and the Use of Peritoneal Dialysis in the United States.
PubMed 文献 · Am J Kidney Dis · 2017-12-23

本研究基于美国肾脏数据系统2006至2012年透析患者,比较有限保险与医疗保险双重资格患者使用腹膜透析的可能性。结果发现有限保险患者透析第4个月前使用腹膜透析的概率低2.4%(95%CI 1.1%-3.7%),但获得医疗保险后转为腹膜透析的比率高3倍(HR 2.9;95%CI 1.8-4.6)。

要点

  • 有限保险患者起始腹膜透析使用率较低
  • 获得医疗保险后转为腹膜透析的比率增加
  • 需加强提供者教育以消除保险障碍

核心结论

  • 尽管医疗保险覆盖腹膜透析起始月份,保险限制仍是许多患者使用腹膜透析的障碍。

研究设计与样本

  • 回顾性队列分析,使用美国肾脏数据系统2006至2012年起始透析的患者。
  • 比较60-64岁有限保险患者与66-70岁医疗保险和医疗补助双重资格患者。

主要发现

  • 有限保险患者透析第4个月前使用腹膜透析的绝对概率低2.4%(95%CI 1.1%-3.7%)。
  • 获得医疗保险后,有限保险患者第4至12个月转为腹膜透析的比率高3倍(HR 2.9;95%CI 1.8-4.6)。

临床怎么用

  • 应教育提供者了解医疗保险报销政策,并扩大透析前教育和培训的可及性。

局限性

  • 观察性研究,可能存在未测量患者层面因素的偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Many patients in the United States have limited or no health insurance at the time they develop end-stage renal disease (ESRD). We examined whether health insurance limitations affected the likelihood of peritoneal dialysis (PD) use. STUDY DESIGN: Retrospective cohort analysis of patients from the US Renal Data System initiating dialysis therapy in 2006 through 2012. SETTING & PARTICIPANTS: We identified socioeconomically similar groups of patients to examine the association between health insurance and PD use. Patients aged 60 to 64 years with "limited insurance" (defined as having Medicaid or no insurance) at ESRD onset were compared with patients aged 66 to 70 years who were dually eligible for Medicare and Medicaid at ESRD onset. PREDICTOR: Type of insurance coverage at ESRD onset. OUTCOMES: The likelihoods of receiving PD before dialysis month 4, when all patients qualified for Medicare due to ESRD, and of switching to PD therapy following receipt of Medicare. RESULTS: After adjusting for observable patient and geographic differences, patients with limited insurance had an absolute 2.4% (95% CI, 1.1%-3.7%) lower probability of PD use by dialysis month 4 compared with patients with Medicare at ESRD onset. The association between insurance and PD use reversed when patients became Medicare eligible; patients with limited insurance had a 3-fold higher rate of switching to PD therapy between months 4 and 12 of dialysis (HR, 2.9; 95% CI, 1.8-4.6) compared with patients with Medicare at ESRD onset. LIMITATIONS: Because this study was observational, there is a potential for bias from unmeasured patient-level factors. CONCLUSIONS: Despite Medicare's policy of covering patients in the month that they initiate PD therapy, insurance limitations remain a barrier to PD use for many patients. Educating providers about Medicare reimbursement policy and expanding access to pre-ESRD education and training may help overcome these barriers.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Perez JJ, Zhao B, Qureshi S, et al. Health Insurance and the Use of Peritoneal Dialysis in the United States. Am J Kidney Dis. 2017. PMID: 29277511. doi:10.1053/j.ajkd.2017.09.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。